This firm develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. And news of a potential licensing agreement is sending shares soaring in morning...

To read the full story on AllPennyStocks.com, click here.

BioRestorative Therapies (NASDAQ:BRTX)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse BioRestorative Therapies
BioRestorative Therapies (NASDAQ:BRTX)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse BioRestorative Therapies